Skip to main content
Log in

Interactions between chronic haloperidol treatment and cocaine in rats: an animal model of intermittent cocaine use in neuroleptic treated populations

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

This experiment investigated the possibility that rats maintained on chronic haloperidol treatment would show increased behavioral responsiveness to cocaine, similar to that observed in human stimulant abusers who are chronically treated with neuroleptics. Thus, the effects on locomotion and stereotyped behavior of intermittent injections of cocaine were investigated in female rats receiving chronic haloperidol treatment. Daily injections of haloperidol (0.2 mg/kg, IP) or vehicle were administered for 6, 12 or 18 days prior to the start of testing with cocaine and were then continued throughout cocaine testing. All rats received four doses of cocaine (0.0, 3.0, 7.5, or 15.0 mg/kg, IP) in random order with an intervening vehicle day between successive drug days. The four dose sequence of cocaine was repeated a total of four times. Initial cocaine administration produced dose dependent increases in locomotion and stereotyped behavior. When the sequence of cocaine doses was repeated, differences among treatment groups emerged. Groups treated with haloperidol exhibited heightened locomotion in response to cocaine and with repeated injections, showed a higher rate of behavioral sensitization than control animals. These differences in the behavioral response to cocaine were maintained for at least 2 months following termination of daily haloperidol treatment. In order to examine the mechanisms underlying this heightened responsiveness to cocaine, apomorphine-induced locomotion (dose range, 0–250 µg/kg, SC) was determined. Regardless of dose, rats treated with haloperidol showed different temporal patterns of locomotion in response to apomorphine suggesting that the increased response to cocaine was related to changes in dopaminergic receptor sensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bhattacharyya A, Aulakh C, Pradhan S, Ghosh P, Pradhan S (1979) Modification of behavioral and neurochemical effects of cocaine by haloperidol. Arch Int Pharmacodyn Ther 238:71–80

    Google Scholar 

  • Blaha CD, Lane RF (1987) Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine in the striatum and nucleus accumbens in vivo. Neurosci Lett 78:199–204

    Google Scholar 

  • Bunney BS (1984) Antipsychotic drug effects on the electrical activity of dopaminergic neurons. TINS 1:212–215

    Google Scholar 

  • Bunney BS, Grace AA (1978) Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci 23:1715–1728

    Google Scholar 

  • Bunney BS, Walters JR, Roth RH, Aghajanian GK (1973) Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560–571

    Google Scholar 

  • Carlsson A (1978) Mechanism of action of neuroleptic drugs. In: Lipton MA, DiMascio A, Killian KF (eds) Psychopharmacology: a generation in progress. Raven Press, New York, pp 1057–1070

    Google Scholar 

  • Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3:1607–1619

    Google Scholar 

  • Costall B, Naylor RJ (1975) The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic system. Eur J Pharmacol 32:87–92

    Google Scholar 

  • Creese I, Iversen SD (1975) The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83:419–436

    Google Scholar 

  • Csernansky JG, Bellows EP, Barnes DE, Lombrozo L (1990) Sensitization to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing. Psychopharmacology 101:519–524

    Google Scholar 

  • Dewey KJ, Fibiger HC (1983) The effects of dose and duration of chronic pimozide administration on dopamine receptor supersensitivity. Naunyn-Schmiedeberg's Arch Pharmacol 322:261–270

    Google Scholar 

  • Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274–5278

    Google Scholar 

  • Di Chiara G, Porceddu ML, Vargiu L, Argiolas P, Gessa GL (1976) Evidence for dopamine receptors mediating sedation in mouse brain. Nature 264:564–566

    Google Scholar 

  • Dixon L, Hass G, Weiden P, Sweeney J, Frances A (1991) Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. Am J Psychiatry 148:224–230

    Google Scholar 

  • Dustan R, Jackson DM (1976) The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol. Psychopharmacology 38:105–114

    Google Scholar 

  • Ellinwood EH (1967) Amphetamine psychosis: I. description of individuals and process. J Nerv Ment Dis 144:273–283

    Google Scholar 

  • Ellinwood EH, Kilbey MM (1977) Chronic stimulant intoxication models of psychosis. In: Hanin I, Usdin E (eds) Animal models in psychiatry and neurology. Pergamon Press, New York, pp 61–74

    Google Scholar 

  • Gawin FH (1991) Cocaine addiction: psychology and neurophysiology. Science 251:580–586

    Google Scholar 

  • Groves PN, Rebec GV (1976) Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs. Annu Rev Psychiatry 27:91–27

    Google Scholar 

  • Halperin R, Guerin JJ, Davis KL (1983) Chronic administration of three neuroleptics: effects of behavioral supersensitivity mediated by two different brain regions in the rat. Life Sci 33:585–592

    Google Scholar 

  • Hill RT (1970) Facilitation of conditioned reinforcement as a mechanism of psychomotor stimulation. In Costa E, Garattini S (eds) Amphetamines and related compounds. Raven Press, New York, pp 781–795

    Google Scholar 

  • Ho BT, Taylor DL, Estevez VS (1977) Behavioral effects of cocainemetabolic and neurochemical approach. In: Ellinwood EH, Kilbey MM (eds) Cocaine and other stimulants. Advances in behavioral biology, vol 21. Plenum Press, New York, pp 229–240

    Google Scholar 

  • Imperato A, Gianluigi T, Frau R, Di Chiara G (1988) Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. J Pharmacol Exp Ther 245:257–264

    Google Scholar 

  • Janowsky DS, Davis JM (1976) Methylphenidate, dextroamphetamine, and levamphetamine: effects on schizophrenic symptoms. Arch Gen Psychiatry 33:304–308

    Google Scholar 

  • Kehr W, Carlsson A, Lindqvist M (1975) Biochemical aspects of dopamine agonists. In: Calne DB, Chase TN, Barbeau A (eds) Advances in neurology, vol 9. Raven Press, New York, pp 185–195

    Google Scholar 

  • Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507–522

    Google Scholar 

  • Kuczenski R, Segal D.S., Aizenstein ML (1991) Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J Neurosci 11:2703–2712

    Google Scholar 

  • Lane RF, Blaha CD (1987) Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action. Brain Res B 18:135–138

    Google Scholar 

  • Lyon M, Robbins TW (1975) The action of central nervous system drugs: a general theory concerning amphetamine effects. In: Essman W, Valzelli L (eds) Current developments in psychopharmacology, vol 2. Spectrum, New York, pp 79–163

    Google Scholar 

  • Maclennan A, Maier S (1983) Coping and the stress-induced potentiation of stimulant induced stereotypy in the rat. Science 219:1091–1093

    Google Scholar 

  • Mesulam MM (1986) Cocaine and Tourette's syndrome. N Engl J Med 315:398

    Google Scholar 

  • Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, Morrison RL, Yadalam KG (1990) Prevalance of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 16:31–56

    Google Scholar 

  • Pettit HO, Justice JB (1989) Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol Biochem Behav 34:899–904

    Google Scholar 

  • Post RM (1981) Central stimulants: clinical and experimental evidence on tolerance and sensitization. In: Israel Y, Glaser FB, Kalant H, Popham RE, Schmidt W, Smart RG (eds) Research advances in alcohol and drug problems, vol 6. Plenum Press, New York, pp 1–65

    Google Scholar 

  • Post RM, Rose H (1976) Increasing effects of repetitive cocaine administration in the rat. Nature 260:731–732

    Google Scholar 

  • Prosser JG, Csernansky JG, Hollister LE (1988) Differences in the time course of haloperidol-induced up-regulation of rat striatial and mesolimbic dopamine receptors. Life Sci 43:715–720

    Google Scholar 

  • Radhakishun FS, Van Ree JM (1987) The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens. Eur J Pharmacol 136:41–47

    Google Scholar 

  • Randrup A, Munkvad I (1967) Stereotyped behavior produced by amphetamine in several animal species and man. Psychopharmacologia 11:300–310

    Google Scholar 

  • Randrup A, Munkvad I, Udsen P (1963) Adrenergic mechanisms and amphetamine induced abnormal behavior. Actg Pharmacol Toxicol 20:145–157

    Google Scholar 

  • Rastogi SK, Rastogi RB, Singhal RL, Lapierre YD (1983) Behavioural and biochemical alterations following haloperidol treatment withdrawal: the animal model reexamined. Prog Neuropsychopharmacol 7:153–164

    Google Scholar 

  • Rebec GV, Peirson EE, McPherson FA, Brugge K (1982) Differential sensitivity to amphetamine following long-term treatment with clozapine or haloperidol. Psychopharmacology 77:360–366

    Google Scholar 

  • Richard ML, Liskow BI, Perry PJ (1985) Recent psychostimulant use in hospitalized schizophrenics. J Clin Psychiatry 46:79–83

    Google Scholar 

  • Robbins TW, Mittleman G, O'Brien J, Winn P (1990) The neuropsychological significance of stereotypy induced by stimulant drugs. In: Cooper SJ, Dourish CT (eds) Neurobiology of stereotyped behavior. Clarendon Press, Oxford, pp 25–63

    Google Scholar 

  • Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res R 11:157–198

    Google Scholar 

  • Rylander G (1971) Stereotyped behavior in man following amphetamine abuse. In: Baker SB (ed) The correlation of adverse effects in man with observations in animals. Excerpta Medica, Amsterdam, pp 29–31

    Google Scholar 

  • Scheel-Kruger J, Braestrup C, Nielson M, Golembrowska K, Mogilnicka E (1977) Cocaine: discussion on the role of dopamine in the biochemical mechanism of action. In: Ellinwood EH, Kilbey MM (eds) Cocaine and other stimulants. Advances in behavioral biology, vol 21. Plenum Press, New York, pp 373–408

    Google Scholar 

  • Schneier FR, Siris SG (1987) A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. J Nerv Ment Dis 175:641–652

    Google Scholar 

  • Schnoll SH, Daghestani AN, Hansen TR (1984) Cocaine dependence. Resident Staff Physician 30:24–31

    Google Scholar 

  • Seeger TF, Thal L, Gardner EL (1982) Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol. Psychopharmacology 76:182–187

    Google Scholar 

  • Segal DS, Mandell AJ (1974) Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 2:249–255

    Google Scholar 

  • Skirboll LR, Grace AA, Bunney BS (1979) Dopamine auto-and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists. Science 206:80–82

    Google Scholar 

  • Smith RC, Davis JM (1976) Behavioural evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine. Life Sci 19:725–732

    Google Scholar 

  • Tarsy D, Baldessarini RJ (1974) Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with synaptic function of catecholamines. Neuropharmacology 13:927–940

    Google Scholar 

  • Van Ree JM, Caffe AM, Wolterink G (1982) Non-opiate B-endorphin fragments and dopamine - III. y-Type endorphins and various neuroleptics counteract the hypoactivity elicited by injections of apomorphine into the nucleus accumbens. Neuropharmacology 21:1103–1111

    Google Scholar 

  • Westerink BHC, Horn AS (1979) Do neuroleptics prevent the penetration of dopamine agonists into the brain? Eur J Pharmacol 58:39–48

    Google Scholar 

  • White FJ, Wang RY (1983) Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. Life Sci 32:983–993

    Google Scholar 

  • Wilmot CA, Szczepanik AM (1989) Effects of acute treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain. Brain Res 487:288–298

    Google Scholar 

  • Winer BJ (1962) Statistical principles in experimental design. McGraw Hill, New York

    Google Scholar 

  • Wise RA, Bozarth MA (1987) A psychmotor stimulant theory of addiction. Psychol Rev 94:469–492

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

LeDuc, P.A., Mittleman, G. Interactions between chronic haloperidol treatment and cocaine in rats: an animal model of intermittent cocaine use in neuroleptic treated populations. Psychopharmacology 110, 427–436 (1993). https://doi.org/10.1007/BF02244649

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02244649

Key words

Navigation